PL2805625T5 - Kompozycja odżywcza z prebiotykami i probiotykami - Google Patents

Kompozycja odżywcza z prebiotykami i probiotykami

Info

Publication number
PL2805625T5
PL2805625T5 PL14181368.3T PL14181368T PL2805625T5 PL 2805625 T5 PL2805625 T5 PL 2805625T5 PL 14181368 T PL14181368 T PL 14181368T PL 2805625 T5 PL2805625 T5 PL 2805625T5
Authority
PL
Poland
Prior art keywords
prebiotics
probiotics
nutritional composition
composition
disorder
Prior art date
Application number
PL14181368.3T
Other languages
English (en)
Other versions
PL2805625T3 (pl
Inventor
Jan Knol
Monique Haarman
Johan Garssen
Adrianus Johannes Maria Vriesema
Martine Sandra Alles
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35229644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2805625(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL2805625T3 publication Critical patent/PL2805625T3/pl
Publication of PL2805625T5 publication Critical patent/PL2805625T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL14181368.3T 2005-02-28 2006-02-28 Kompozycja odżywcza z prebiotykami i probiotykami PL2805625T5 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05075486 2005-02-28
EP11162630.5A EP2351492B1 (en) 2005-02-28 2006-02-28 Nutritional composition with probiotics
EP06716673A EP1855550B1 (en) 2005-02-28 2006-02-28 Nutritional composition with probiotics
EP14181368.3A EP2805625B2 (en) 2005-02-28 2006-02-28 Nutritional composition with prebiotics and probiotics
PCT/NL2006/050040 WO2006091103A2 (en) 2005-02-28 2006-02-28 Nutritional composition with probiotics

Publications (2)

Publication Number Publication Date
PL2805625T3 PL2805625T3 (pl) 2019-04-30
PL2805625T5 true PL2805625T5 (pl) 2023-03-13

Family

ID=35229644

Family Applications (3)

Application Number Title Priority Date Filing Date
PL14181368.3T PL2805625T5 (pl) 2005-02-28 2006-02-28 Kompozycja odżywcza z prebiotykami i probiotykami
PL06716673T PL1855550T3 (pl) 2005-02-28 2006-02-28 Kompozycje żywieniowe z probiotykami
PL11162630T PL2351492T3 (pl) 2005-02-28 2006-02-28 Kompozycja odżywcza z probiotykami

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL06716673T PL1855550T3 (pl) 2005-02-28 2006-02-28 Kompozycje żywieniowe z probiotykami
PL11162630T PL2351492T3 (pl) 2005-02-28 2006-02-28 Kompozycja odżywcza z probiotykami

Country Status (16)

Country Link
US (3) US20060194241A1 (pl)
EP (3) EP1855550B1 (pl)
CN (2) CN101128129A (pl)
AT (1) ATE526836T1 (pl)
AU (1) AU2006217160B2 (pl)
BR (1) BRPI0607743B1 (pl)
CA (1) CA2598961C (pl)
DK (2) DK2351492T3 (pl)
ES (3) ES2373971T3 (pl)
MX (1) MX2007010466A (pl)
PL (3) PL2805625T5 (pl)
PT (2) PT2351492E (pl)
RU (2) RU2422025C2 (pl)
TR (1) TR201820329T4 (pl)
WO (1) WO2006091103A2 (pl)
ZA (1) ZA200706875B (pl)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
BRPI0620465A2 (pt) * 2005-12-23 2011-11-16 Nutricia Nv uso de uma composição
JP2009067679A (ja) * 2005-12-27 2009-04-02 Univ Of Tokushima 抗ヒスタミン作用を有する医薬
WO2008015374A2 (en) 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
US20100063002A1 (en) * 2007-03-13 2010-03-11 Bernd Stahl Method of improving skills with a composition comprising non-digestible saccharide
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2008156354A1 (en) * 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
EP2170088A2 (en) * 2007-06-27 2010-04-07 Chr. Hansen A/S Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2173196B1 (en) * 2007-07-06 2011-02-16 N.V. Nutricia Use of probiotics and fibers for diarrhoea
JP2009057346A (ja) * 2007-09-03 2009-03-19 Kirin Holdings Co Ltd 免疫バランス調節用組成物
MX2010002562A (es) 2007-09-07 2011-04-11 Inst Nac De Ciencias Medicas Y Nutricion Uso de los niveles de antigeno secretor, de lewis y de sialilo como predictores para enfermedad.
BRPI0816993A2 (pt) * 2007-09-17 2014-10-07 Nutricia Nv Uso de uma composição, e, composição nutricional
WO2009067000A1 (en) * 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
BRPI0821165B8 (pt) 2007-12-07 2021-05-25 Nutricia Nv uso de uma composição
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
PL2234505T3 (pl) * 2007-12-21 2013-06-28 Nutricia Nv Zastosowanie sfingomieliny i nietrawionych węglowodanów do poprawy mikroflory jelitowej
PT2123168E (pt) * 2008-05-16 2012-03-28 Nestec Sa Lactobacillus paracasei e controlo de peso
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
WO2009151331A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Immune system stimulating nutrition
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
CN101768559B (zh) * 2008-12-31 2012-03-07 生展生物科技股份有限公司 副干酪乳杆菌副干酪亚种菌株及其抑菌组合物和用途
CA2984935C (en) * 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
ES2382263T3 (es) * 2009-05-11 2012-06-06 Nestec S.A. Prevención y tratamiento de la diarrea alérgica
ITMI20091034A1 (it) * 2009-06-11 2010-12-12 Parmalat Spa Specie probiotica di bifidobacterium breve
EP3181134B1 (en) * 2009-06-19 2019-10-30 DuPont Nutrition Biosciences ApS Bifidobacteria for treating diabetes and related conditions
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
EP2459202A1 (en) * 2009-07-31 2012-06-06 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
RU2518293C2 (ru) * 2009-09-17 2014-06-10 Моринага Милк Индастри Ко., Лтд. Средство против ожирения, питание или напиток против ожирения, улучшающее толерантность к глюкозе средство и питание или напиток для улучшения толерантности к глюкозе
EP2308498A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
WO2011071367A1 (en) * 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
RU2425679C1 (ru) * 2010-02-24 2011-08-10 Николай Иванович Зрячкин Способ лечения детей с кишечными коликами
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
IT1405395B1 (it) * 2010-08-05 2014-01-10 Proge Farm Srl Composizioni di probiotici e oli e loro uso.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
PT2734049T (pt) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc Composições e métodos probióticos
US20140220663A1 (en) * 2011-07-06 2014-08-07 Dupont Nutrition Biosciences Aps Method for reducing the viscosity of a microorganism-containing suspension or concentrate
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
FI20116008A0 (fi) * 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2014046804A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
EP3936134B1 (en) * 2012-11-02 2026-03-04 N.V. Nutricia Synbiotics combination for brain improvement
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
BR112016009357B1 (pt) 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
WO2016013928A1 (en) 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
AU2017307952A1 (en) * 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
CN110831609A (zh) * 2017-06-30 2020-02-21 N·V·努特里奇亚 用于预防代谢紊乱的合生素组合物
EP4159224A1 (en) 2017-06-30 2023-04-05 N.V. Nutricia Synbiotic composition for preventing chronic inflammation
CN111698993A (zh) * 2018-02-09 2020-09-22 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
CN111954536A (zh) * 2018-03-23 2020-11-17 森永乳业株式会社 用于预防学龄期及之后的高血糖引起的疾病的婴幼儿用组合物
WO2019212330A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with a specific beta-lactoglobulin peptide
CN116744950A (zh) * 2020-11-24 2023-09-12 强生消费者公司 预防、延迟或改善特应性疾病的方法
CN116287331B (zh) * 2023-01-03 2026-05-19 湖南国测生物科技有限公司 一种罗伊氏乳杆菌检测用引物、试剂盒和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
JP4008974B2 (ja) 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
DK1003532T4 (da) * 1997-07-05 2009-03-02 Nestle Sa Lactobacilli til fremme af tarmcellers mineralabsorption
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1175905A1 (en) 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
CN1164186C (zh) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 益菌奶及其制造方法
DE10206995B4 (de) * 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1374878A1 (en) * 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
CN1212068C (zh) * 2002-11-13 2005-07-27 上海光明乳业股份有限公司 免疫配方奶粉及其制备方法
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
JP4740866B2 (ja) * 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物

Also Published As

Publication number Publication date
US20090004164A1 (en) 2009-01-01
ES2373971T3 (es) 2012-02-10
US20060194241A1 (en) 2006-08-31
PL2351492T3 (pl) 2015-02-27
CN104223094A (zh) 2014-12-24
RU2422025C2 (ru) 2011-06-27
PL1855550T3 (pl) 2012-03-30
MX2007010466A (es) 2007-10-11
RU2007135869A (ru) 2009-04-10
PT1855550E (pt) 2012-01-16
ATE526836T1 (de) 2011-10-15
EP2351492A1 (en) 2011-08-03
ES2702631T5 (es) 2023-03-22
US20160206667A1 (en) 2016-07-21
ES2702631T3 (es) 2019-03-04
AU2006217160B2 (en) 2011-09-15
ES2524344T3 (es) 2014-12-05
PL2805625T3 (pl) 2019-04-30
AU2006217160A1 (en) 2006-08-31
RU2595396C2 (ru) 2016-08-27
TR201820329T4 (tr) 2019-01-21
EP2805625A3 (en) 2015-03-25
CA2598961C (en) 2016-09-13
ZA200706875B (en) 2008-11-26
WO2006091103A3 (en) 2006-10-26
EP2805625B2 (en) 2022-11-23
EP1855550B1 (en) 2011-10-05
BRPI0607743B1 (pt) 2020-09-15
US10071125B2 (en) 2018-09-11
EP2805625A2 (en) 2014-11-26
WO2006091103A2 (en) 2006-08-31
DK2351492T3 (en) 2014-12-01
EP1855550A2 (en) 2007-11-21
EP2351492B1 (en) 2014-08-20
CN101128129A (zh) 2008-02-20
BRPI0607743A2 (pt) 2010-03-16
CA2598961A1 (en) 2006-08-31
PT2351492E (pt) 2014-12-02
US9314047B2 (en) 2016-04-19
DK1855550T3 (da) 2012-01-16
EP2805625B1 (en) 2018-10-03
RU2011110056A (ru) 2012-09-27

Similar Documents

Publication Publication Date Title
ZA200706875B (en) Nutritional composition with probiotics
GB2460781B (en) Probiotic bifidobacterium strains
GB2465051B (en) Probiotic bifidobacterium strains
PL1963483T3 (pl) Nowe szczepy Lactobacillus i ich zastosowanie przeciwko Helicobacter pylori
EP1539927A4 (en) PROBIOTIC BACTERIA: LACTOBACILLUS FERMENTUM
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
IL160050A0 (en) Probiotic lactobacillus casei strains
IL160048A0 (en) Probiotic bifidobacterium strains
IL160049A0 (en) Probiotic lactobacillus salivarius strains
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
PL2173196T3 (pl) Zastosowanie probiotyków i włókien w biegunce
PL2219658T3 (pl) Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
PL2209527T3 (pl) Kompozycje farmaceutyczne zawierające probiotyki L.acidophilus i Bifidobacterium lactis do stosowania w leczeniu zaburzenia czynnościowego jelit
WO2008042101A3 (en) Probiotics for use in reducing the incidence and duration of illness
EP1853284A4 (en) USE OF LACTOBACILLUS KEFIRANOFACIENS AS PROBIOTIC AND SYNBIOTIC
GB2430366B (en) Probiotic Lactobacillus acidophilus composition for dogs and cats
PL1796698T3 (pl) Szczep lactobacillus acidophilus wykazujący właściwości przeciwbólowe w układzie pokarmowym
AU2003250503A8 (en) Probiotic therapies using lactobacillus reuteri
ZA200407456B (en) Lactobacillus strains.
PL1782818T3 (pl) Kompozycja farmaceutyczna zawierająca Bacillus Coagulans i simetikon do leczenia patologii żołądkowo-jelitowych
AU2006905424A0 (en) Probiotic lactobacillus strains
RU2006118105A (ru) Способ лечения дисбактериоза кишечника
TH144912A (th) การลดความเสี่ยงในการเป็นโรคท้องเสีย